Hair care stocks surged as China’s anti-hair loss market shows explosive growth potential. Shuiyang Co. jumped over 12%, while Langzi Co., Jiuzhitang and other sector players hit daily trading limits after official data revealed over 250 million Chinese suffer from hair loss – about one in six people. The hair transplant and treatment market is expanding at a 17.3% annual clip, emerging as the next major growth sector following medical aesthetics.
The market is being driven by younger demographics, with post-90s consumers dominating hair transplant procedures and post-00s joining the prevention trend. Meituan platform data shows 55% of hair treatment users are under 35, including 23% aged 20-25, reflecting how hair loss concerns are affecting younger generations sooner than before. Many are taking preventive action at early signs of thinning hair.
Two key trends are shaping the sector: growing demand for early intervention products and increasing preference for aesthetic solutions over medical treatments. Searches for “hairline” outpace “hair transplant” by 16 percentage points, indicating consumers prioritize cosmetic improvements. As awareness grows and social acceptance increases, China’s hair care market is evolving into a multi-billion dollar opportunity with strong long-term growth prospects.
Related topics：
